Star Health & Allied Insurance Company Ltd
₹455.90
(1.08%)
Tue, 17 Mar 2026, 11:10 pm
Finance
Life/Health Insurance
24.5KStar Health & Allied Insurance Company Price to Sales Ratio (P/S)
| Particulars | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 | 0 | 0 | 0 | 49.81 | 38.28 | 32.80 |
| Price to book ratio | 0 | 0 | 0 | 0 | 0 | 6.42 | 4.59 | 4.80 | 2.98 |
| Price to sales ratio | 0 | 0 | 0 | 0 | 0 | 3.74 | 2.55 | 2.31 | 1.31 |
| Price to cash flow ratio | 0 | 0 | 0 | 0 | 0 | 1370 | 25.65 | 25.49 | 15.84 |
| Enterprise value | 0 | 0 | 0 | 0 | 0 | 403.73B | 312.82B | 328.14B | 216.56B |
| Enterprise value to EBITDA ratio | - | - | - | - | - | - | - | - | - |
| Debt to equity ratio | 0 | 0.24 | 0.18 | 0.13 | 0.06 | 0.11 | 0.07 | 0.07 | 0.07 |
| Return on equity % | 0 | 16.52 | 10.59 | 15.98 | -37.01 | -19.65 | 9.56 | 12.81 | 9.46 |
Star Health & Allied Insurance Company Ltd Price to Sales Ratio
The Star Health & Allied Insurance Company Ltd Price to Sales Ratio is a key financial metric used by investors to evaluate Star Health & Allied Insurance Company Ltd's valuation, profitability, and overall financial performance. Tracking the Star Health & Allied Insurance Company Ltd Price to Sales Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Star Health & Allied Insurance Company Ltd (NSE: STARHEALTH, BSE: 543412) is currently trading at ₹455.90, with a market capitalization of ₹265.72B. As a leading company in the Finance sector and Life/Health insurance industry, monitoring the Star Health & Allied Insurance Company Ltd Price to Sales Ratio is essential for fundamental analysis.
Star Health & Allied Insurance Company Ltd Price to Sales Ratio Current Value
The current Star Health & Allied Insurance Company Ltd Price to Sales Ratio stands at 1.31.
The Star Health & Allied Insurance Company Ltd Price to Sales Ratio has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Star Health & Allied Insurance Company Ltd Price to Sales Ratio Historical Trend
The Star Health & Allied Insurance Company Ltd Price to Sales Ratio has shown the following historical trend:
- 2024: 1.31
- 2023: 2.31
- 2022: 2.55
- 2021: 3.74
- 2020: 0
The decline in Star Health & Allied Insurance Company Ltd Price to Sales Ratio indicates improving financial efficiency or better earnings growth.
What Star Health & Allied Insurance Company Ltd Price to Sales Ratio Indicates for Investors
The Star Health & Allied Insurance Company Ltd Price to Sales Ratio plays a crucial role in understanding the company's financial health and valuation.
The P/S ratio helps evaluate valuation relative to company revenue.
Star Health & Allied Insurance Company Ltd Price to Sales Ratio Analysis Summary
The Star Health & Allied Insurance Company Ltd Price to Sales Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Star Health & Allied Insurance Company Ltd Price to Sales Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Star Health & Allied Insurance Company Ltd Price to Sales Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800